Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?

Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg. 2008 Sep; 79(3):320-30.

View in: PubMed

subject areas

Adolescent
Adult
Aged
AIDS-Related Opportunistic Infections
Animals
Anti-Bacterial Agents
Anti-Infective Agents
Antimalarials
Cohort Studies
Drug Resistance
Escherichia coli
Female
HIV Infections
Humans
Kenya
Malaria, Falciparum
Male
Middle Aged
Plasmodium falciparum
Prospective Studies
Streptococcus pneumoniae

authors with profiles

Eric Mintz

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support